CAMBRIDGE, Mass., Jan. 24 /PRNewswire-FirstCall/ -- Vertex
Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will
webcast its corporate presentation at the Wachovia Securities Small and
Mid-Cap Healthcare Conference. The presentation will be delivered by John
Alam, M.D., Vertex's Executive Vice President, Medicines Development and
Chief Medical Officer, on Tuesday, January 30, 2007 at 10:15 a.m. EST.
The presentation will be webcast live and may be accessed from the
'Events Calendar' on the home page of Vertex's website at http://www.vrtx.com. A
replay of the webcast will also be available on the Company's website until
February 13, 2007. To ensure a timely connection, it is recommended that
users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company
committed to the discovery and development of breakthrough small molecule
drugs for serious diseases. The Company's strategy is to commercialize its
products both independently and in collaboration with major pharmaceutical
companies. Vertex's product pipeline is focused on viral diseases,
inflammation, autoimmune diseases, cancer, pain and bacterial infection.
Vertex co-discovered the HIV protease inhibitor, Lexiva, with
GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of
companies.
Vertex's press releases are available at http://www.vrtx.com.
Vertex Contact:
Lora Pike, Manager, Investor Relations, (617) 444-6755
SOURCE Vertex Pharmaceuticals Incorporated
 back to top
Related links:
http://www.vrtx.com
http://www.prnewswire.com/comp/938395.html /
CONTACT:
Lora Pike, Manager, Investor Relations, of
Vertex Pharmaceuticals Incorporated, +1-617-444-6755
|
